Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: Prevention of multiple system atrophy using human bone marrow-derived mesenchymal stem cells by reducing polyamine and cholesterol-induced neural damages

Fig. 1

Mesenchymal stem cell (MSC) transplantation ameliorates double-toxin-induced behavior disorders. The performance on the rotarod test was impaired following the double-toxin injection. However, the impairment was ameliorated in the double-toxin-injected MSC-transplanted group (a). Double-toxin-induced bradykinesia was ameliorated in the double-toxin-injected MSC-transplanted group (b). The stride length of the forelimb (c) and hindlimb (d) was increased to a greater extent following MSC treatment in the double-toxin injection group. Values are presented as mean ± standard deviation of 10 rats. *P < 0.05, significant difference vs. the saline-injected group. #P < 0.05, significant difference among the double-toxin-injected group. $ < 0.05, significant difference between two numbers of the MSC-injected group

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512